Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brandts

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Tropical Medicine and Hygiene|November 1, 1995
Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor productionP G Kremsner, S Winkler, C Brandts, et al.
International Journal of Oncology|July 26, 2006
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancerJ C Becker, C Müller-Tidow, M Stolte, et al.
Leukemia|June 5, 2014
Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitorsC Wichmann, I Quagliano-Lo Coco, Ö Yildiz, et al.
Leukemia|March 29, 2017
Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipientS Herold, M Kuhn, M V Bonin, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
The American Journal of Tropical Medicine and Hygiene|November 1, 1995
Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor productionP G Kremsner, S Winkler, C Brandts, et al.
International Journal of Oncology|July 26, 2006
Acetylsalicylic acid enhances antiproliferative effects of the EGFR inhibitor gefitinib in the absence of activating mutations in gastric cancerJ C Becker, C Müller-Tidow, M Stolte, et al.
Leukemia|June 5, 2014
Activating c-KIT mutations confer oncogenic cooperativity and rescue RUNX1/ETO-induced DNA damage and apoptosis in human primary CD34+ hematopoietic progenitorsC Wichmann, I Quagliano-Lo Coco, Ö Yildiz, et al.
Leukemia|March 29, 2017
Donor cell leukemia: evidence for multiple preleukemic clones and parallel long term clonal evolution in donor and recipientS Herold, M Kuhn, M V Bonin, et al.
Pageof 2